Hydrogen Research Study
← Back to Research Library
Review or synthesisReviewHydrogen Water / Reduced Water

Redox Regulation by Reduced Waters as Active Hydrogen Donors and Intracellular ROS Scavengers for Prevention of type 2 Diabetes

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Type 2 Diabetes / Redox Regulation
Evidence type Review or synthesis
Publication type Review
Hydrogen method Hydrogen Water / Reduced Water

H2HUBB TAKEAWAY

This chapter describes reduced waters as active-hydrogen donors and intracellular ROS scavengers, reports redox effects on insulin-signaling regulation, and summarizes improvement in diabetes-related measures among 356 Nordenau-water users. It is a mechanistic synthesis with observational clinical evidence.

What the Findings Mean

The chapter links historical reduced-water observations with insulin-signaling redox mechanisms, but the human component is observational and does not isolate H2 from the broader intervention.

What the Researchers Studied

The chapter combines chemical/cellular redox assays, protein tyrosine phosphatase signaling, and a clinical observation involving 356 people with diabetes drinking Nordenau water.

What Effects Did Molecular Hydrogen Have?

Reduced waters scavenged intracellular ROS and suppressed protein tyrosine phosphatase activity; the reported clinical cohort showed improvement in diabetes-related test parameters after six days, correlated with blood ROS changes.

Why These Findings Matter

The chapter links historical reduced-water observations with insulin-signaling redox mechanisms, but the human component is observational and does not isolate H2 from the broader intervention.

How Strong Is This Evidence?

Mechanistic review/book chapter with supporting observational human data.

Technical Study Details

Model: Mechanistic assays plus cited clinical observation
Sample: Clinical component reported 356 patients with diabetes
DOI: 10.1007/978-1-4020-5476-1_15

Limitations and Safety

Limitations: Not a randomized trial; combines heterogeneous evidence and historical active-hydrogen concepts; molecular hydrogen is not isolated as the only active component.

Safety: No systematic adverse-event analysis is provided.

Original Study and H2HUBB Research Context

This publication is an exact-identity member of H2HUBB Gold v1.1.4. The materialized summary is bounded to the certified source evidence used for this import. Source basis: Springer chapter identity plus source abstract. Original/source record.